Literature DB >> 8648762

Moloney murine leukemia virus activates NF-kappa B.

J Pak1, D V Faller.   

Abstract

Nonacutely transforming retroviruses, such as Moloney murine leukemia virus (M-MuLV), differ from transforming viruses in their mechanisms of tumor induction. While the transforming viruses cause tumors by transduction of oncogenes, the leukemia retroviruses, lacking oncogenes, employ other mechanisms, including promoter insertion and enhancer activation. Although these two mechanisms occur in many tumors induced by leukemia viruses, a substantial proportion of such tumors do not show site-specific proviral insertions. Thus, other, unidentified virus-driven mechanisms may participate in tumorigenesis. In these studies, we show that infection of cells by M-MuLV activates expression of Rel family transcription factors. In murine cells chronically infected with M-MuLV, gel shift analyses with kappaB DNA-binding motifs from the murine immunoglobulin kappa light chain enhancer demonstrated induction of at least two distinct kappaB enhancer-binding complexes. Supershifting and immunoblotting analyses defined p50, p52, RelB, and c-Rel subunits as constituents of these virus-induced protein complexes. Transient transfections performed with kappaB-dependent reporter plasmids showed transcriptional activation in M-MuLV-infected cells relative to uninfected cells. Induction of Rel/NF-kappaB transcription factor activity by M-MuLV infection may prove relevant to the mechanism of M-MuLV-induced leukemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648762      PMCID: PMC190311     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

Review 2.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.

Authors:  A A Beg; A S Baldwin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

3.  Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-I kappa B complex.

Authors:  S Li; J M Sedivy
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 4.  The I kappa B proteins: members of a multifunctional family.

Authors:  T D Gilmore; P J Morin
Journal:  Trends Genet       Date:  1993-12       Impact factor: 11.639

5.  NF-kappa B activation by ultraviolet light not dependent on a nuclear signal.

Authors:  Y Devary; C Rosette; J A DiDonato; M Karin
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

6.  A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation.

Authors:  M T Diaz-Meco; E Berra; M M Municio; L Sanz; J Lozano; I Dominguez; V Diaz-Golpe; M T Lain de Lera; J Alcamí; C V Payá; F Arenzana-Seisedos; J L Virelizier; J Moscat
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  An increase in p50/p65 NF-kB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte.

Authors:  K Conant; W J Atwood; R Traub; C Tornatore; E O Major
Journal:  Virology       Date:  1994-12       Impact factor: 3.616

8.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.

Authors:  F Mercurio; J A DiDonato; C Rosette; M Karin
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

9.  Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1.

Authors:  T S Finco; A S Baldwin
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

10.  A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.

Authors:  E B Traenckner; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  4 in total

1.  Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences.

Authors:  S Y Choi; K van de Mark; D V Faller
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

2.  Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.

Authors:  Ana L Abujamra; Remco A Spanjaard; Idowu Akinsheye; Xiansi Zhao; Douglas V Faller; Sajal K Ghosh
Journal:  Virology       Date:  2005-11-14       Impact factor: 3.616

3.  Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus.

Authors:  S P Guo; W L Wang; Y Q Zhai; Y L Zhao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

4.  Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation.

Authors:  H T Kim; W Qiang; P K Wong; G Stoica
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.